| Pharmaceutical active ingredients: |
| Metamizole Sodium |
| Available forms, composition and doses of Novalgin: |
| Drops; Oral; Metamizole Sodium 500 mg / mlInjectable; Injection; Metamizole Sodium 500 mg / mlSuppositories; Rectal; Metamizole Sodium 1000 mgSuppositories; Rectal; Metamizole Sodium 300 mgSyrup; Oral; Metamizole Sodium 250 mg / 5 mlTablets, Film-Coated; Oral; Metamizole Sodium 500 mgTablets, Oral; Metamizole Sodium 1000 mgTablets, Oral; Metamizole Sodium 500 mg |
| Novalgin medical category: |
| Human:Analgesics (non-opioid) and antipyretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB02 - Metamizole Sodium |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |